What is the purpose of this trial?
This study is a double-blind, randomized, placebo-controlled, parallel group, two-site study designed to assess the effects of varenicline as compared with placebo on responses to in vivo alcohol cue exposure in the human laboratory setting.
Ages: 21 years and younger
National Institute on Alcohol Abuse and Alcoholism
Start Date: 05/15/2017
End Date: 11/30/2017
Last Updated: 02/22/2018
Study HIC#: 1611018672